Big data

North America is seeing a hiring boom in pharmaceutical industry AI roles 

The proportion of pharmaceutical companies hiring for cloud related positions rose to a year-high in August 2021, with 42.7% of the companies included in our analysis recruiting for at least one such position.

Powered by 

North America extended its dominance for Artificial Intelligence (AI) hiring among pharmaceutical industry companies in the three months ending September.

The number of roles in North America made up 50.5% of total AI jobs – up from 46.3% in the same quarter last year.

That was followed by Asia-Pacific, which saw a 2.7 year-on-year percentage point change in AI roles.

The figures are compiled by GlobalData, which tracks the number of new job postings from key companies in various sectors over time. Using textual analysis, these job advertisements are then classified thematically.

GlobalData's thematic approach to sector activity seeks to group key company information by topic to see which companies are best placed to weather the disruptions coming to their industries.

These key themes, which include artificial intelligence, are chosen to cover "any issue that keeps a CEO awake at night".

Tracking them across job advertisements allows us to see which companies are leading the way on specific issues and which are dragging their heels – and importantly where the market is expanding and contracting.

Which countries are seeing the most growth for AI roles in pharmaceuticals?

The fastest growing country was the United States, which saw 46.3% of all AI job adverts in the three months ending June last year, increasing to 50.5% in the three months ending September this year.

That was followed by China (up 2.1 percentage points), Poland (up 1.9), and France (up 1.3).

The top country for AI roles in the pharmaceutical industry is the United States which saw 50.5% of all roles in the three months ending September.

Which cities are the biggest hubs for AI workers in pharmaceuticals?

Some 4.2% of all pharmaceutical industry AI roles were advertised in Cambridge (United States) in the three months ending September – more than any other city.

That was followed by Boston (United States) with 4.2%, Cambridge (United Kingdom) with 3.9 %, and South San Francisco (United States) with 2.6%.

Go to article: Home | Drug dealing goes digital Go to article: In this issueGo to article: ContentsGo to article: SyrenisGo to article: Astrix Go to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Thermo Fisher Scientific Company InsightGo to article: Thermo Fisher ScientificGo to article: CommentGo to article: Life sciences professionals prioritise quality over cost for PV automationGo to article: Slow progress for male contraceptive trialsGo to article: Accelerated approval designations in ChinaGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: In DepthGo to article: The dark consequences of supply shortagesGo to article: Digitising the pharma supply chainGo to article: Covid-19 vaccine pricing varies wildly by country and company Go to article: Psychedelics and mental health: the next big thing?Go to article: Schizophrenia drug landscape: a stagnant field on the cusp of change?Go to article: Are supercomputers set to transform pharma R&D?Go to article: BEA TechnologiesGo to article: LabcorpGo to article: In DataGo to article: North America's AI hiring boomGo to article: The pharma companies leading the way in artificial intelligenceGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue